{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:50:41Z","timestamp":1792698641895,"version":"4.5.0"},"reference-count":177,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T00:00:00Z","timestamp":1764979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-025-01989-1","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T12:25:04Z","timestamp":1765023904000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["RETRACTED ARTICLE: Integrative multi-omics profiling for early diagnosis, stratification and personalized management of chronic kidney disease: a new paradigm\u00a0"],"prefix":"10.1007","volume":"26","author":[{"given":"Yue","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0655-1060","authenticated-orcid":false,"given":"Soroush","family":"Taherkhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4069-9868","authenticated-orcid":false,"given":"Khusniddin","family":"Saidov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8374-0977","authenticated-orcid":false,"given":"Marhabo","family":"Matniyozova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,6]]},"reference":[{"issue":"11","key":"1989_CR1","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41581-020-0286-5","volume":"16","author":"S Eddy","year":"2020","unstructured":"Eddy S, Mariani LH, Kretzler M. Integrated multi-omics approaches to improve classification of chronic kidney disease. Nat Rev Nephrol. 2020;16(11):657\u201368.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"1989_CR2","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3390\/ijms23010336","volume":"23","author":"M Provenzano","year":"2021","unstructured":"Provenzano M, Serra R, Garofalo C, Michael A, Crugliano G, Battaglia Y, Andreucci M. OMICS in chronic kidney disease: focus on prognosis and prediction. Int J Mol Sci. 2021;23(1):336.","journal-title":"Int J Mol Sci"},{"issue":"W1","key":"1989_CR3","doi-asserted-by":"publisher","first-page":"W520","DOI":"10.1093\/nar\/gkad408","volume":"51","author":"FC Qian","year":"2023","unstructured":"Qian FC, Zhou LW, Li YY, Yu ZM, Li LD, Wang YZ, Li CQ. SEanalysis 2.0: a comprehensive super-enhancer regulatory network analysis tool for human and mouse. Nucleic Acids Res. 2023;51(W1):W520\u20137.","journal-title":"Nucleic Acids Res"},{"key":"1989_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117225","volume":"178","author":"F Li","year":"2024","unstructured":"Li F, Tian J, Zhang L, He H, Song D. A multi-omics approach to reveal critical mechanisms of activator protein 1 (AP-1). Biomed Pharmacother. 2024;178:117225.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"1989_CR5","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1109\/TCBB.2021.3059046","volume":"19","author":"X Li","year":"2021","unstructured":"Li X, Xiang J, Wu FX, Li M. A dual ranking algorithm based on the multiplex network for heterogeneous complex disease analysis. IEEE ACM Trans Comput Biol Bioinform. 2021;19(4):1993\u20132002.","journal-title":"IEEE ACM Trans Comput Biol Bioinform"},{"issue":"12","key":"1989_CR6","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1093\/ndt\/gfv364","volume":"31","author":"K Cisek","year":"2016","unstructured":"Cisek K, Krochmal M, Klein J, Mischak H. The application of multi-omics and systems biology to identify therapeutic targets in chronic kidney disease. Nephrol Dial Transplant. 2016;31(12):2003\u201311.","journal-title":"Nephrol Dial Transplant"},{"key":"1989_CR7","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/dom.13416","volume":"20","author":"S Mulder","year":"2018","unstructured":"Mulder S, Hamidi H, Kretzler M, Ju W. An integrative systems biology approach for precision medicine in diabetic kidney disease. Diabetes Obes Metab. 2018;20:6\u201313.","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"1989_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/ajt.13881","volume":"17","author":"SV Bontha","year":"2017","unstructured":"Bontha SV, Maluf DG, Mueller TF, Mas VR. Systems biology in kidney transplantation: the application of multi-omics to a complex model. Am J Transplant. 2017;17(1):11\u201321.","journal-title":"Am J Transplant"},{"key":"1989_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101367","volume":"54","author":"S Liu","year":"2021","unstructured":"Liu S, Gui Y, Wang MS, Zhang L, Xu T, Pan Y, et al. Serum integrative omics reveals the landscape of human diabetic kidney disease. Mol Metab. 2021;54:101367.","journal-title":"Mol Metab"},{"key":"1989_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.01065","volume":"10","author":"M Chierici","year":"2020","unstructured":"Chierici M, Bussola N, Marcolini A, Francescatto M, Zandon\u00e0 A, Trastulla L, et al. Integrative network fusion: a multi-omics approach in molecular profiling. Front Oncol. 2020;10:1065.","journal-title":"Front Oncol"},{"issue":"11","key":"1989_CR11","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.3390\/biom11111597","volume":"11","author":"EI Usova","year":"2021","unstructured":"Usova EI, Alieva AS, Yakovlev AN, Alieva MS, Prokhorikhin AA, Konradi AO, Baragetti A. Integrative analysis of multi-omics and genetic approaches\u2014a new level in atherosclerotic cardiovascular risk prediction. Biomolecules. 2021;11(11):1597.","journal-title":"Biomolecules"},{"issue":"9","key":"1989_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094820","volume":"22","author":"V La Cognata","year":"2021","unstructured":"La Cognata V, Morello G, Cavallaro S. Omics data and their integrative analysis to support stratified medicine in neurodegenerative diseases. Int J Mol Sci. 2021;22(9):4820.","journal-title":"Int J Mol Sci"},{"key":"1989_CR13","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jprot.2017.08.010","volume":"188","author":"BC Yoo","year":"2018","unstructured":"Yoo BC, Kim KH, Woo SM, Myung JK. Clinical multi-omics strategies for the effective cancer management. J Proteome. 2018;188:97\u2013106.","journal-title":"J Proteome"},{"issue":"8","key":"1989_CR14","first-page":"576","volume":"13","author":"C Hu","year":"2021","unstructured":"Hu C, Jia W. Multi-omics profiling: the way toward precision medicine in metabolic diseases. J Mol Cell Biol. 2021;13(8):576\u201393.","journal-title":"J Mol Cell Biol"},{"issue":"1","key":"1989_CR15","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1053\/j.ajkd.2017.12.008","volume":"72","author":"EP Rhee","year":"2018","unstructured":"Rhee EP. How omics data can be used in nephrology. Am J Kidney Dis. 2018;72(1):129\u201335.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"1989_CR16","first-page":"270","volume":"88","author":"A Panunzio","year":"2021","unstructured":"Panunzio A, Tafuri A, Princiotta A, Gentile I, Mazzucato G, Trabacchin N, Cerruto MA. Omics in urology: an overview on concepts, current status and future perspectives. Urol J. 2021;88(4):270\u20139.","journal-title":"Urol J"},{"issue":"6","key":"1989_CR17","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.1109\/TCBB.2022.3143770","volume":"19","author":"W Li","year":"2022","unstructured":"Li W, Wang S, Xu J, Xiang J. Inferring latent microRNA-disease associations on a gene-mediated tripartite heterogeneous multiplexing network. IEEE ACM Trans Comput Biol Bioinf. 2022;19(6):3190\u2013201.","journal-title":"IEEE ACM Trans Comput Biol Bioinf"},{"issue":"8","key":"1989_CR18","doi-asserted-by":"publisher","first-page":"765","DOI":"10.3109\/08860220903100713","volume":"31","author":"S Stojnev","year":"2009","unstructured":"Stojnev S, Pejcic M, Dolicanin Z, Velickovic LJ, Dimov I, Stefanovic V. Challenges of genomics and proteomics in nephrology. Ren Fail. 2009;31(8):765\u201372.","journal-title":"Ren Fail"},{"issue":"1","key":"1989_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s40620-017-0448-0","volume":"31","author":"JG Nestor","year":"2018","unstructured":"Nestor JG, Groopman EE, Gharavi AG. Towards precision nephrology: the opportunities and challenges of genomic medicine. J Nephrol. 2018;31(1):47\u201360.","journal-title":"J Nephrol"},{"issue":"1","key":"1989_CR20","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s43162-024-00341-5","volume":"36","author":"N Aderinto","year":"2024","unstructured":"Aderinto N, Olatunji G, Kokori E, Ogieuhi IJ, Babalola AE, Ayodeji KB, Ishola IV. Genomic insights into renal diseases: advancements and implications. Egypt J Intern Med. 2024;36(1):73.","journal-title":"Egypt J Intern Med"},{"issue":"7","key":"1989_CR21","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1093\/ndt\/gfx211","volume":"33","author":"FP Schena","year":"2018","unstructured":"Schena FP, Nistor I, Curci C. Transcriptomics in kidney biopsy is an untapped resource for precision therapy in nephrology: a systematic review. Nephrol Dial Transplant. 2018;33(7):1094\u2013102.","journal-title":"Nephrol Dial Transplant"},{"key":"1989_CR22","doi-asserted-by":"publisher","first-page":"125052","DOI":"10.1016\/j.talanta.2023.125052","volume":"266","author":"X Chen","year":"2024","unstructured":"Chen X, Chen C, Tian X, He L, Zuo E, Liu P, Lv X. DBAN: an improved dual branch attention network combined with serum Raman spectroscopy for diagnosis of diabetic kidney disease. Talanta. 2024;266:125052.","journal-title":"Talanta"},{"key":"1989_CR23","doi-asserted-by":"publisher","first-page":"1182803","DOI":"10.3389\/fphar.2023.1182803","volume":"14","author":"L Tang","year":"2023","unstructured":"Tang L, Wang Y, Gong X, Xiang J, Zhang Y, Xiang Q, Li J. Integrated transcriptome and metabolome analysis to investigate the mechanism of intranasal insulin treatment in a rat model of vascular dementia. Front Pharmacol. 2023;14:1182803.","journal-title":"Front Pharmacol"},{"issue":"3","key":"1989_CR24","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3904\/kjim.2020.415","volume":"36","author":"J Kim","year":"2021","unstructured":"Kim J, Park J. Single-cell transcriptomics: a novel precision medicine technique in nephrology. Korean J Intern Med. 2021;36(3):479.","journal-title":"Korean J Intern Med"},{"key":"1989_CR25","doi-asserted-by":"crossref","unstructured":"Saliba A, Du Y, Feng T, Garmire L. Multi-omics integration in nephrology: advances, challenges, and future directions. Seminars in nephrology. Volume 44. WB Saunders; 2024, November. p. 151584. 6.","DOI":"10.1016\/j.semnephrol.2025.151584"},{"issue":"12","key":"1989_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/jpm14121157","volume":"14","author":"C Delrue","year":"2024","unstructured":"Delrue C, Speeckaert MM. Decoding kidney pathophysiology: omics-driven approaches in precision medicine. J Pers Med. 2024;14(12):1157.","journal-title":"J Pers Med"},{"issue":"2","key":"1989_CR27","doi-asserted-by":"publisher","DOI":"10.36922\/bh.5548","volume":"3","author":"W Materko","year":"2025","unstructured":"Materko W, Nascimento DGB, da Silva AS. Factor analysis of electrocardiographic findings, anthropometric measures, and age in patients with chronic kidney disease. Brain & Heart. 2025;3(2):5548.","journal-title":"Brain & Heart"},{"key":"1989_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2025.123694","author":"Q Peng","year":"2025","unstructured":"Peng Q, Zhang H, Li Z. Methyltransferase-like 16 drives diabetic nephropathy progression via epigenetic suppression of V-set pre-B cell surrogate light chain 3. Life Sci. 2025. https:\/\/doi.org\/10.1016\/j.lfs.2025.123694.","journal-title":"Life Sci"},{"key":"1989_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2025.123746","author":"Q Peng","year":"2025","unstructured":"Peng Q, Zhang H, Li Z. KAT2A-mediated H3K79 succinylation promotes ferroptosis in diabetic nephropathy by regulating SAT2. Life Sci. 2025. https:\/\/doi.org\/10.1016\/j.lfs.2025.123746.","journal-title":"Life Sci"},{"issue":"5","key":"1989_CR30","doi-asserted-by":"publisher","first-page":"4595","DOI":"10.3390\/cimb46050279","volume":"46","author":"K Chavali","year":"2024","unstructured":"Chavali K, Coker H, Youngblood E, Karaduta O. Proteogenomics in nephrology: a new frontier in nephrological research. Curr Issues Mol Biol. 2024;46(5):4595\u2013608.","journal-title":"Curr Issues Mol Biol"},{"issue":"12","key":"1989_CR31","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/nrneph.2009.183","volume":"5","author":"MPW Smith","year":"2009","unstructured":"Smith MPW, Banks RE, Wood SL, Lewington AJ, Selby PJ. Application of proteomic analysis to the study of renal diseases. Nat Rev Nephrol. 2009;5(12):701\u201312.","journal-title":"Nat Rev Nephrol"},{"key":"1989_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2023.1338270","volume":"14","author":"TD Cummins","year":"2023","unstructured":"Cummins TD, Thongboonkerd V. Proteomics, mass spectrometry and bioinformatics in renal pathophysiology. Front Physiol. 2023;14:1338270.","journal-title":"Front Physiol"},{"issue":"1","key":"1989_CR33","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.kint.2016.08.021","volume":"91","author":"S Kalim","year":"2017","unstructured":"Kalim S, Rhee EP. An overview of renal metabolomics. Kidney Int. 2017;91(1):61\u20139.","journal-title":"Kidney Int"},{"issue":"5","key":"1989_CR34","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s11255-013-0600-2","volume":"46","author":"A Zhang","year":"2014","unstructured":"Zhang A, Sun H, Qiu S, Wang X. Metabolomics insights into pathophysiological mechanisms of nephrology. Int Urol Nephrol. 2014;46(5):1025\u201330.","journal-title":"Int Urol Nephrol"},{"key":"1989_CR35","doi-asserted-by":"crossref","unstructured":"Weiss RH. March). Metabolomics and metabolic reprogramming in kidney cancer. Seminars in nephrology. WB Saunders. 2018(38}; 175\u201382. 2.","DOI":"10.1016\/j.semnephrol.2018.01.006"},{"issue":"1","key":"1989_CR36","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nrneph.2011.152","volume":"8","author":"RH Weiss","year":"2012","unstructured":"Weiss RH, Kim K. Metabolomics in the study of kidney diseases. Nat Rev Nephrol. 2012;8(1):22\u201333.","journal-title":"Nat Rev Nephrol"},{"key":"1989_CR37","doi-asserted-by":"crossref","unstructured":"Natarajan R. Introduction: epigenetics and the kidney. Seminars in nephrology. Volume 33. Elsevier; 2013, July. pp. 311\u20133. 4.","DOI":"10.1016\/j.semnephrol.2013.05.003"},{"key":"1989_CR38","doi-asserted-by":"publisher","first-page":"1163001","DOI":"10.3389\/fendo.2023.1163001","volume":"14","author":"N Sandholm","year":"2023","unstructured":"Sandholm N, Dahlstr\u00f6m EH, Groop PH. Genetic and epigenetic background of diabetic kidney disease. Front Endocrinol. 2023;14:1163001.","journal-title":"Front Endocrinol"},{"issue":"6","key":"1989_CR39","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41581-019-0135-6","volume":"15","author":"M Kato","year":"2019","unstructured":"Kato M, Natarajan R. Epigenetics and epigenomics in diabetic kidney disease and metabolic memory. Nat Rev Nephrol. 2019;15(6):327\u201345.","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"1989_CR40","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1159\/000326901","volume":"34","author":"CA B\u00f6ger","year":"2011","unstructured":"B\u00f6ger CA, Heid IM. Chronic kidney disease: novel insights from genome-wide association studies. Kidney Blood Press Res. 2011;34(4):225\u201334.","journal-title":"Kidney Blood Press Res"},{"issue":"2","key":"1989_CR41","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nrneph.2011.189","volume":"8","author":"CM O\u2019seaghdha","year":"2012","unstructured":"O\u2019seaghdha CM, Fox CS. Genome-wide association studies of chronic kidney disease: what have we learned? Nat Rev Nephrol. 2012;8(2):89\u201399.","journal-title":"Nat Rev Nephrol"},{"key":"1989_CR42","first-page":"417","volume-title":"Seminars in dialysis","author":"K Luttropp","year":"2009","unstructured":"Luttropp K, Lindholm B, Carrero JJ, Glorieux G, Schepers E, Vanholder R, et al. July). Progress in uremic toxin research: genetics\/genomics in chronic kidney disease\u2014towards personalized medicine? In: Seminars in dialysis, vol. 22. Oxford, UK: Blackwell Publishing Ltd; 2009. p. 417\u201322."},{"issue":"1","key":"1989_CR43","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/ki.2011.359","volume":"81","author":"BJ Keller","year":"2012","unstructured":"Keller BJ, Martini S, Sedor JR, Kretzler M. A systems view of genetics in chronic kidney disease. Kidney Int. 2012;81(1):14\u201321.","journal-title":"Kidney Int"},{"issue":"5","key":"1989_CR44","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1172\/JCI80877","volume":"125","author":"M Verbitsky","year":"2015","unstructured":"Verbitsky M, Sanna-Cherchi S, Fasel DA, Levy B, Kiryluk K, Wuttke M, et al. Genomic imbalances in pediatric patients with chronic kidney disease. J Clin Invest. 2015;125(5):2171\u20138.","journal-title":"J Clin Invest"},{"issue":"1","key":"1989_CR45","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s12967-018-1664-7","volume":"16","author":"M Ca\u00f1adas-Garre","year":"2018","unstructured":"Ca\u00f1adas-Garre M, Anderson K, McGoldrick J, Maxwell AP, McKnight AJ. Genomic approaches in the search for molecular biomarkers in chronic kidney disease. J Transl Med. 2018;16(1):292.","journal-title":"J Transl Med"},{"issue":"4","key":"1989_CR46","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.trsl.2012.01.020","volume":"159","author":"W Ju","year":"2012","unstructured":"Ju W, Smith S, Kretzler M. Genomic biomarkers for chronic kidney disease. Transl Res. 2012;159(4):290\u2013302.","journal-title":"Transl Res"},{"issue":"1","key":"1989_CR47","doi-asserted-by":"publisher","first-page":"4800","DOI":"10.1038\/s41467-018-07260-4","volume":"9","author":"X Xu","year":"2018","unstructured":"Xu X, Eales JM, Akbarov A, Guo H, Becker L, Talavera D, Tomaszewski M. Molecular insights into genome-wide association studies of chronic kidney disease-defining traits. Nat Commun. 2018;9(1):4800.","journal-title":"Nat Commun"},{"issue":"7","key":"1989_CR48","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1056\/NEJMra2308577","volume":"391","author":"A Vivante","year":"2024","unstructured":"Vivante A. Genetics of chronic kidney disease. N Engl J Med. 2024;391(7):627\u201339.","journal-title":"N Engl J Med"},{"key":"1989_CR49","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ymeth.2021.08.001","volume":"198","author":"XY Li","year":"2022","unstructured":"Li XY, Xiang J, Wu FX, Li M. NetAUC: a network-based multi-biomarker identification method by AUC optimization. Methods. 2022;198:56\u201364.","journal-title":"Methods"},{"issue":"3","key":"1989_CR50","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1681\/ASN.2015101152","volume":"28","author":"A Parsa","year":"2017","unstructured":"Parsa A, Kanetsky PA, Xiao R, Gupta J, Mitra N, Limou S, et al. Genome-wide association of CKD progression: the chronic renal insufficiency cohort study. J Am Soc Nephrol. 2017;28(3):923\u201334.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"1989_CR51","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1681\/ASN.2022060725","volume":"34","author":"M Verbitsky","year":"2023","unstructured":"Verbitsky M, Krishnamurthy S, Krithivasan P, Hughes D, Khan A, Maras\u00e0 M, Gharavi AG. Genomic disorders in CKD across the lifespan. J Am Soc Nephrol. 2023;34(4):607\u201318.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"1989_CR52","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/ng.568","volume":"42","author":"A K\u00f6ttgen","year":"2010","unstructured":"K\u00f6ttgen A, Pattaro C, B\u00f6ger CA, Fuchsberger C, Olden M, Glazer NL, Fox CS. New loci associated with kidney function and chronic kidney disease. Nat Genet. 2010;42(5):376\u201384.","journal-title":"Nat Genet"},{"issue":"7","key":"1989_CR53","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1038\/s41591-022-01869-1","volume":"28","author":"A Khan","year":"2022","unstructured":"Khan A, Turchin MC, Patki A, Srinivasasainagendra V, Shang N, Nadukuru R, Kiryluk K. Genome-wide polygenic score to predict chronic kidney disease across ancestries. Nat Med. 2022;28(7):1412\u201320.","journal-title":"Nat Med"},{"issue":"1","key":"1989_CR54","volume":"2016","author":"S Granata","year":"2016","unstructured":"Granata S, Dalla Gassa A, Bellin G, Lupo A, Zaza G. Transcriptomics: a step behind the comprehension of the polygenic influence on oxidative stress, immune deregulation, and mitochondrial dysfunction in chronic kidney disease. Biomed Res Int. 2016;2016(1):9290857.","journal-title":"Biomed Res Int"},{"issue":"3","key":"1989_CR55","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.kint.2018.10.029","volume":"95","author":"J Rowland","year":"2019","unstructured":"Rowland J, Akbarov A, Eales J, Xu X, Dormer JP, Guo H, et al. Uncovering genetic mechanisms of kidney aging through transcriptomics, genomics, and epigenomics. Kidney Int. 2019;95(3):624\u201335.","journal-title":"Kidney Int"},{"issue":"6390","key":"1989_CR56","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1126\/science.aar2131","volume":"360","author":"J Park","year":"2018","unstructured":"Park J, Shrestha R, Qiu C, Kondo A, Huang S, Werth M, et al. Single-cell transcriptomics of the mouse kidney reveals potential cellular targets of kidney disease. Science. 2018;360(6390):758\u201363.","journal-title":"Science"},{"issue":"5","key":"1989_CR57","doi-asserted-by":"publisher","first-page":"F1001","DOI":"10.1152\/ajprenal.00640.2020","volume":"320","author":"LF Chou","year":"2021","unstructured":"Chou LF, Chen TW, Yang HY, Tian YC, Chang MY, Hung CC, et al. Transcriptomic signatures of exacerbated progression in leptospirosis subclinical chronic kidney disease with secondary nephrotoxic injury. Am J Physiol Renal Physiol. 2021;320(5):F1001\u201318.","journal-title":"Am J Physiol Renal Physiol"},{"key":"1989_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.116590","volume":"314","author":"J Shen","year":"2023","unstructured":"Shen J, Liu Y, Wang Q, Chen H, Hu Y, Guo X, et al. Integrated network pharmacology, transcriptomics, and metabolomics analysis to reveal the mechanism of salt Eucommiae cortex in the treatment of chronic kidney disease mineral bone disorders via the PPARG\/AMPK signaling pathway. J Ethnopharmacol. 2023;314:116590.","journal-title":"J Ethnopharmacol"},{"issue":"2","key":"1989_CR59","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ekir.2019.11.005","volume":"5","author":"F Tajti","year":"2020","unstructured":"Tajti F, Kuppe C, Antoranz A, Ibrahim MM, Kim H, Ceccarelli F, et al. A functional landscape of CKD entities from public transcriptomic data. Kidney Int Rep. 2020;5(2):211\u201324.","journal-title":"Kidney Int Rep"},{"key":"1989_CR60","doi-asserted-by":"crossref","unstructured":"Chade AR, Sivasankaran SK, Sitz R, McCarthy EA, Eirin A. (2025). Renal single-nuclear transcriptomics identifies novel therapeutic targets in a preclinical model of chronic kidney disease. Kidney360, 10\u201334067.","DOI":"10.34067\/KID.0000000945"},{"issue":"1","key":"1989_CR61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0262667","volume":"17","author":"E Petra","year":"2022","unstructured":"Petra E, Siwy J, Vlahou A, Jankowski J. Urine peptidome in combination with transcriptomics analysis highlights MMP7, MMP14 and PCSK5 for further investigation in chronic kidney disease. PLoS One. 2022;17(1):e0262667.","journal-title":"PLoS One"},{"key":"1989_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1063083","volume":"14","author":"R Agoro","year":"2023","unstructured":"Agoro R, Nookaew I, Noonan ML, Marambio YG, Liu S, Chang W, et al. Single cell cortical bone transcriptomics define novel osteolineage gene sets altered in chronic kidney disease. Front Endocrinol. 2023;14:1063083.","journal-title":"Front Endocrinol"},{"key":"1989_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fbinf.2024.1352594","volume":"4","author":"AO Slabowska","year":"2024","unstructured":"Slabowska AO, Pyke C, Hvid H, Jessen LE, Baumgart S, Das V. A systematic evaluation of state-of-the-art deconvolution methods in spatial transcriptomics: insights from cardiovascular disease and chronic kidney disease. Front Bioinform. 2024;4:1352594.","journal-title":"Front Bioinform"},{"issue":"7","key":"1989_CR64","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/s41588-022-01097-w","volume":"54","author":"H Liu","year":"2022","unstructured":"Liu H, Doke T, Guo D, Sheng X, Ma Z, Park J, et al. Epigenomic and transcriptomic analyses define core cell types, genes and targetable mechanisms for kidney disease. Nat Genet. 2022;54(7):950\u201362.","journal-title":"Nat Genet"},{"issue":"1","key":"1989_CR65","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12882-025-04103-5","volume":"26","author":"M Ma","year":"2025","unstructured":"Ma M, Luo Q, Chen L, Liu F, Yin L, Guan B. Novel insights into kidney disease: the scRNA-seq and spatial transcriptomics approaches: a literature review. BMC Nephrol. 2025;26(1):181.","journal-title":"BMC Nephrol"},{"issue":"6","key":"1989_CR66","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202202013RR","volume":"37","author":"D Chen","year":"2023","unstructured":"Chen D, Shao M, Song Y, Ren G, Guo F, Fan X, et al. Single-cell RNA\u2010seq with spatial transcriptomics to create an atlas of human diabetic kidney disease. FASEB J. 2023;37(6):e22938.","journal-title":"FASEB J"},{"issue":"1","key":"1989_CR67","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13073-024-01356-x","volume":"16","author":"S Si","year":"2024","unstructured":"Si S, Liu H, Xu L, Zhan S. Identification of novel therapeutic targets for chronic kidney disease and kidney function by integrating multi-omics proteome with transcriptome. Genome Med. 2024;16(1):84.","journal-title":"Genome Med"},{"issue":"9","key":"1989_CR68","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.2337\/db10-1181","volume":"60","author":"KI Woroniecka","year":"2011","unstructured":"Woroniecka KI, Park ASD, Mohtat D, Thomas DB, Pullman JM, Susztak K. Transcriptome analysis of human diabetic kidney disease. Diabetes. 2011;60(9):2354\u201369.","journal-title":"Diabetes"},{"key":"1989_CR69","doi-asserted-by":"crossref","unstructured":"Fan Y, Yi Z, D\u2019Agati VD, Sun Z, Zhong F, Zhang W, et al. Comparison of kidney transcriptomic profiles of early and advanced diabetic nephropathy reveals potential new mechanisms for disease progression. Diabetes. 2019;68(12):2301\u201314.","DOI":"10.2337\/db19-0204"},{"key":"1989_CR70","doi-asserted-by":"crossref","unstructured":"Wardowska A, Komorniczak M, Bu\u0142\u0142o-Piontecka B, D\u0229bska-\u015alizie\u0144 MA, Piku\u0142a M. Transcriptomic and epigenetic alterations in dendritic cells correspond with chronic kidney disease in lupus nephritis. Front Immunol. 2019;10:2026.","DOI":"10.3389\/fimmu.2019.02026"},{"key":"1989_CR71","doi-asserted-by":"crossref","unstructured":"Ko YA, Susztak K. Epigenomics: the science of no-longer-junk DNA. Why study it in chronic kidney disease? In: Seminars in nephrology, vol. 33. WB Saunders; p. 354\u201362.","DOI":"10.1016\/j.semnephrol.2013.05.007"},{"issue":"2","key":"1989_CR72","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/ki.2015.148","volume":"88","author":"MA Reddy","year":"2015","unstructured":"Reddy MA, Natarajan R. Recent developments in epigenetics of acute and chronic kidney diseases. Kidney Int. 2015;88(2):250\u201361.","journal-title":"Kidney Int"},{"issue":"7","key":"1989_CR73","doi-asserted-by":"publisher","first-page":"F757","DOI":"10.1152\/ajprenal.00306.2014","volume":"307","author":"LJ Smyth","year":"2014","unstructured":"Smyth LJ, Duffy S, Maxwell AP, McKnight AJ. Genetic and epigenetic factors influencing chronic kidney disease. Am J Physiol-Renal Physiol. 2014;307(7):F757-76.","journal-title":"Am J Physiol-Renal Physiol"},{"issue":"1","key":"1989_CR74","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/ki.2010.335","volume":"79","author":"RS Dwivedi","year":"2011","unstructured":"Dwivedi RS, Herman JG, McCaffrey TA, Raj DS. Beyond genetics: epigenetic code in chronic kidney disease. Kidney Int. 2011;79(1):23\u201332.","journal-title":"Kidney Int"},{"issue":"6","key":"1989_CR75","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1159\/000517073","volume":"145","author":"Z Li","year":"2021","unstructured":"Li Z, Li N. Epigenetic modification drives acute kidney injury-to-chronic kidney disease progression. Nephron. 2021;145(6):737\u201347.","journal-title":"Nephron"},{"issue":"1","key":"1989_CR76","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00441-017-2588-x","volume":"369","author":"N Wanner","year":"2017","unstructured":"Wanner N, Bechtel-Walz W. Epigenetics of kidney disease. Cell Tissue Res. 2017;369(1):75\u201392.","journal-title":"Cell Tissue Res"},{"issue":"1","key":"1989_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01297-7","volume":"8","author":"AY Chu","year":"2017","unstructured":"Chu AY, Tin A, Schlosser P, Ko YA, Qiu C, Yao C, et al. Epigenome-wide association studies identify DNA methylation associated with kidney function. Nat Commun. 2017;8(1):1286.","journal-title":"Nat Commun"},{"issue":"3","key":"1989_CR78","doi-asserted-by":"publisher","first-page":"366","DOI":"10.4161\/epi.27161","volume":"9","author":"LJ Smyth","year":"2014","unstructured":"Smyth LJ, McKay GJ, Maxwell AP, McKnight AJ. DNA hypermethylation and DNA hypomethylation is present at different loci in chronic kidney disease. Epigenetics. 2014;9(3):366\u201376.","journal-title":"Epigenetics"},{"issue":"12","key":"1989_CR79","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1681\/ASN.2011060629","volume":"22","author":"MA Reddy","year":"2011","unstructured":"Reddy MA, Natarajan R. Epigenetics in diabetic kidney disease. J Am Soc Nephrol. 2011;22(12):2182\u20135.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"1989_CR80","doi-asserted-by":"publisher","first-page":"660","DOI":"10.3892\/br.2016.781","volume":"5","author":"SN Uwaezuoke","year":"2016","unstructured":"Uwaezuoke SN, Okafor HU, Muoneke VN, Odetunde OI, Odimegwu CL. Chronic kidney disease in children and the role of epigenetics: future therapeutic trajectories. Biomed Rep. 2016;5(6):660\u20134.","journal-title":"Biomed Rep"},{"key":"1989_CR81","doi-asserted-by":"crossref","unstructured":"Wing MR, Ramezani A, Gill HS, Devaney JM, Raj DS. Epigenetics of progression of chronic kidney disease: fact or fantasy? Seminars in nephrology. Volume 33. WB Saunders; 2013, July. pp. 363\u201374. 4.","DOI":"10.1016\/j.semnephrol.2013.05.008"},{"issue":"1","key":"1989_CR82","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-35485-x","volume":"13","author":"HY Sung","year":"2023","unstructured":"Sung HY, Lee S, Han M, An WJ, Ryu H, Kang E, et al. Epigenome-wide association study of diabetic chronic kidney disease progression in the Korean population: the KNOW-CKD study. Sci Rep. 2023;13(1):8175.","journal-title":"Sci Rep"},{"issue":"1","key":"1989_CR83","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/s41467-024-45295-y","volume":"15","author":"Y Yan","year":"2024","unstructured":"Yan Y, Liu H, Abedini A, Sheng X, Palmer M, Li H, Susztak K. Unraveling the epigenetic code: human kidney DNA methylation and chromatin dynamics in renal disease development. Nat Commun. 2024;15(1):873.","journal-title":"Nat Commun"},{"issue":"suppl4","key":"1989_CR84","doi-asserted-by":"publisher","first-page":"iv72","DOI":"10.1093\/ndt\/gft025","volume":"29","author":"B Tampe","year":"2014","unstructured":"Tampe B, Zeisberg M. Contribution of genetics and epigenetics to progression of kidney fibrosis. Nephrol Dial Transplant. 2014;29(suppl4):iv72-9.","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"1989_CR85","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.2337\/db20-0382","volume":"69","author":"A Bansal","year":"2020","unstructured":"Bansal A, Balasubramanian S, Dhawan S, Leung A, Chen Z, Natarajan R. Integrative omics analyses reveal epigenetic memory in diabetic renal cells regulating genes associated with kidney dysfunction. Diabetes. 2020;69(11):2490\u2013502.","journal-title":"Diabetes"},{"issue":"5","key":"1989_CR86","doi-asserted-by":"publisher","first-page":"796","DOI":"10.3390\/genes13050796","volume":"13","author":"F Liu","year":"2022","unstructured":"Liu F, Chen J, Li Z, Meng X. Recent advances in epigenetics of age-related kidney diseases. Genes. 2022;13(5):796.","journal-title":"Genes"},{"issue":"7","key":"1989_CR87","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.3390\/genes14071489","volume":"14","author":"JE Kim","year":"2023","unstructured":"Kim JE, Jo MJ, Cho E, Ahn SY, Kwon YJ, Gim JA, Ko GJ. The effect of DNA methylation in the development and progression of chronic kidney disease in the general population: an epigenome-wide association study using the Korean genome and epidemiology study database. Genes. 2023;14(7):1489.","journal-title":"Genes"},{"issue":"1","key":"1989_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34963-6","volume":"13","author":"LJ Smyth","year":"2022","unstructured":"Smyth LJ, Dahlstr\u00f6m EH, Syreeni A, Kerr K, Kilner J, Doyle R, et al. Epigenome-wide meta-analysis identifies DNA methylation biomarkers associated with diabetic kidney disease. Nat Commun. 2022;13(1):7891.","journal-title":"Nat Commun"},{"issue":"46","key":"1989_CR89","doi-asserted-by":"publisher","first-page":"29013","DOI":"10.1073\/pnas.2005905117","volume":"117","author":"X Sheng","year":"2020","unstructured":"Sheng X, Qiu C, Liu H, Gluck C, Hsu JY, He J, et al. Systematic integrated analysis of genetic and epigenetic variation in diabetic kidney disease. Proc Natl Acad Sci U S A. 2020;117(46):29013\u201324.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1989_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2023.100550","author":"P Schlosser","year":"2023","unstructured":"Schlosser P, Grams ME, Rhee EP. Proteomics: progress and promise of high-throughput proteomics in chronic kidney disease. Mol Cell Proteomics. 2023. https:\/\/doi.org\/10.1016\/j.mcpro.2023.100550.","journal-title":"Mol Cell Proteomics"},{"key":"1989_CR91","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jprot.2018.09.020","volume":"193","author":"M Ca\u00f1adas-Garre","year":"2019","unstructured":"Ca\u00f1adas-Garre M, Anderson K, McGoldrick J, Maxwell AP, McKnight AJ. Proteomic and metabolomic approaches in the search for biomarkers in chronic kidney disease. J Proteome. 2019;193:93\u2013122.","journal-title":"J Proteome"},{"issue":"2","key":"1989_CR92","doi-asserted-by":"publisher","DOI":"10.3390\/biom10020257","volume":"10","author":"Y Romanova","year":"2020","unstructured":"Romanova Y, Laikov A, Markelova M, Khadiullina R, Makseev A, Hasanova M, et al. Proteomic analysis of human serum from patients with chronic kidney disease. Biomolecules. 2020;10(2):257.","journal-title":"Biomolecules"},{"issue":"1","key":"1989_CR93","doi-asserted-by":"publisher","DOI":"10.1186\/s12014-015-9092-7","volume":"12","author":"MA \u00d8vrehus","year":"2015","unstructured":"\u00d8vrehus MA, Z\u00fcrbig P, Vikse BE, Hallan SI. Urinary proteomics in chronic kidney disease: diagnosis and risk of progression beyond albuminuria. Clin Proteomics. 2015;12(1):21.","journal-title":"Clin Proteomics"},{"issue":"12","key":"1989_CR94","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1093\/ndt\/gfw337","volume":"32","author":"J Siwy","year":"2017","unstructured":"Siwy J, Z\u00fcrbig P, Argiles A, Beige J, Haubitz M, Jankowski J, et al. Noninvasive diagnosis of chronic kidney diseases using urinary proteome analysis. Nephrol Dial Transplant. 2017;32(12):2079\u201389.","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"1989_CR95","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.2337\/dc24-0290","volume":"47","author":"Z Ye","year":"2024","unstructured":"Ye Z, Zhang Y, Zhang Y, Yang S, He P, Liu M, et al. Large-scale proteomics improve prediction of chronic kidney disease in people with diabetes. Diabetes Care. 2024;47(10):1757\u201363.","journal-title":"Diabetes Care"},{"issue":"1","key":"1989_CR96","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-64833-8","volume":"14","author":"Z Makhammajanov","year":"2024","unstructured":"Makhammajanov Z, Kabayeva A, Auganova D, Tarlykov P, Bukasov R, Turebekov D, et al. Candidate protein biomarkers in chronic kidney disease: a proteomics study. Sci Rep. 2024;14(1):14014.","journal-title":"Sci Rep"},{"issue":"4","key":"1989_CR97","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/prca.201500075","volume":"10","author":"V L\u2019Imperio","year":"2016","unstructured":"L\u2019Imperio V, Smith A, Chinello C, Pagni F, Magni F. Proteomics and glomerulonephritis: a complementary approach in renal pathology for the identification of chronic kidney disease related markers. PROTEOMICS\u2013Clinical Appl. 2016;10(4):371\u201383.","journal-title":"PROTEOMICS\u2013Clinical Appl"},{"issue":"4","key":"1989_CR98","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nrneph.2014.247","volume":"11","author":"H Mischak","year":"2015","unstructured":"Mischak H, Delles C, Vlahou A, Vanholder R. Proteomic biomarkers in kidney disease: issues in development and implementation. Nat Rev Nephrol. 2015;11(4):221\u201332.","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"1989_CR99","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1093\/ndt\/gfz242","volume":"36","author":"F Verbeke","year":"2021","unstructured":"Verbeke F, Siwy J, Van Biesen W, Mischak H, Pletinck A, Schepers E, et al. The urinary proteomics classifier chronic kidney disease 273 predicts cardiovascular outcome in patients with chronic kidney disease. Nephrol Dial Transplant. 2021;36(5):811\u20138.","journal-title":"Nephrol Dial Transplant"},{"issue":"13","key":"1989_CR100","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21134802","volume":"21","author":"YE Glazyrin","year":"2020","unstructured":"Glazyrin YE, Veprintsev DV, Ler IA, Rossovskaya ML, Varygina SA, Glizer SL, et al. Proteomics-based machine learning approach as an alternative to conventional biomarkers for differential diagnosis of chronic kidney diseases. Int J Mol Sci. 2020;21(13):4802.","journal-title":"Int J Mol Sci"},{"key":"1989_CR101","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cca.2013.03.033","volume":"422","author":"YY Zhao","year":"2013","unstructured":"Zhao YY. Metabolomics in chronic kidney disease. Clin Chim Acta. 2013;422:59\u201369.","journal-title":"Clin Chim Acta"},{"issue":"5","key":"1989_CR102","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrneph.2017.30","volume":"13","author":"B Hocher","year":"2017","unstructured":"Hocher B, Adamski J. Metabolomics for clinical use and research in chronic kidney disease. Nat Rev Nephrol. 2017;13(5):269\u201384.","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"1989_CR103","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1681\/ASN.2018030256","volume":"29","author":"ME Grams","year":"2018","unstructured":"Grams ME, Shafi T, Rhee EP. Metabolomics research in chronic kidney disease. J Am Soc Nephrol. 2018;29(6):1588\u201390.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"1989_CR104","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1159\/000446484","volume":"43","author":"EP Rhee","year":"2016","unstructured":"Rhee EP, Clish CB, Wenger J, Roy J, Elmariah S, Pierce KA, et al. Metabolomics of chronic kidney disease progression: a case-control analysis in the chronic renal insufficiency cohort study. Am J Nephrol. 2016;43(5):366\u201374.","journal-title":"Am J Nephrol"},{"issue":"1","key":"1989_CR105","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-33377-8","volume":"13","author":"LA Dahabiyeh","year":"2023","unstructured":"Dahabiyeh LA, Nimer RM, Sumaily KM, Alabdaljabar MS, Jacob M, Sabi EM, et al. Metabolomics profiling distinctively identified end-stage renal disease patients from chronic kidney disease patients. Sci Rep. 2023;13(1):6161.","journal-title":"Sci Rep"},{"key":"1989_CR106","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.redox.2016.09.014","volume":"10","author":"H Chen","year":"2016","unstructured":"Chen H, Cao G, Chen DQ, Wang M, Vaziri ND, Zhang ZH, et al. Metabolomics insights into activated redox signaling and lipid metabolism dysfunction in chronic kidney disease progression. Redox Biol. 2016;10:168\u201378.","journal-title":"Redox Biol"},{"issue":"2","key":"1989_CR107","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.bbrc.2014.02.021","volume":"445","author":"T Kobayashi","year":"2014","unstructured":"Kobayashi T, Yoshida T, Fujisawa T, Matsumura Y, Ozawa T, Yanai H, et al. A metabolomics-based approach for predicting stages of chronic kidney disease. Biochem Biophys Res Commun. 2014;445(2):412\u20136.","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"1989_CR108","doi-asserted-by":"publisher","first-page":"577","DOI":"10.2217\/bmm-2019-0008","volume":"13","author":"S Kalantari","year":"2019","unstructured":"Kalantari S, Nafar M. An update of urine and blood metabolomics in chronic kidney disease. Biomark Med. 2019;13(7):577\u201396.","journal-title":"Biomark Med"},{"issue":"1","key":"1989_CR109","doi-asserted-by":"publisher","DOI":"10.1038\/srep26137","volume":"6","author":"T Kimura","year":"2016","unstructured":"Kimura T, Hamase K, Miyoshi Y, Yamamoto R, Yasuda K, Mita M, et al. Chiral amino acid metabolomics for novel biomarker screening in the prognosis of chronic kidney disease. Sci Rep. 2016;6(1):26137.","journal-title":"Sci Rep"},{"issue":"3","key":"1989_CR110","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1053\/j.jrn.2021.05.005","volume":"32","author":"A Tariq","year":"2022","unstructured":"Tariq A, Chen J, Yu B, Boerwinkle E, Coresh J, Grams ME, Rebholz CM. Metabolomics of dietary acid load and incident chronic kidney disease. J Ren Nutr. 2022;32(3):292\u2013300.","journal-title":"J Ren Nutr"},{"issue":"5","key":"1989_CR111","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1093\/ckj\/sfy037","volume":"11","author":"R Davies","year":"2018","unstructured":"Davies R. The metabolomic quest for a biomarker in chronic kidney disease. Clin Kidney J. 2018;11(5):694\u2013703.","journal-title":"Clin Kidney J"},{"issue":"10","key":"1989_CR112","doi-asserted-by":"publisher","first-page":"3802","DOI":"10.1021\/acs.jproteome.6b00583","volume":"15","author":"ZH Zhang","year":"2016","unstructured":"Zhang ZH, Chen H, Vaziri ND, Mao JR, Zhang L, Bai X, Zhao YY. Metabolomic signatures of chronic kidney disease of diverse etiologies in the rats and humans. J Proteome Res. 2016;15(10):3802\u201312.","journal-title":"J Proteome Res"},{"issue":"8","key":"1989_CR113","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12083018","volume":"12","author":"P Krisanapan","year":"2023","unstructured":"Krisanapan P, Tangpanithandee S, Thongprayoon C, Pattharanitima P, Cheungpasitporn W. Revolutionizing chronic kidney disease management with machine learning and artificial intelligence. J Clin Med. 2023;12(8):3018.","journal-title":"J Clin Med"},{"key":"1989_CR114","doi-asserted-by":"crossref","unstructured":"Khalid, F., Alsadoun, L., Khilji, F., Mushtaq, M., Eze-Odurukwe, A., Mushtaq, M. M.,\u2026 KHILJI, F. (2024). Predicting the progression of chronic kidney disease: a systematic review of artificial intelligence and machine learning approaches. Cureus, 16(5).","DOI":"10.7759\/cureus.60145"},{"key":"1989_CR115","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.future.2020.04.036","volume":"111","author":"F Ma","year":"2020","unstructured":"Ma F, Sun T, Liu L, Jing H. Detection and diagnosis of chronic kidney disease using deep learning-based heterogeneous modified artificial neural network. Future Gener Comput Syst. 2020;111:17\u201326.","journal-title":"Future Gener Comput Syst"},{"key":"1989_CR116","doi-asserted-by":"publisher","DOI":"10.1016\/j.dajour.2023.100169","volume":"6","author":"R Sawhney","year":"2023","unstructured":"Sawhney R, Malik A, Sharma S, Narayan V. A comparative assessment of artificial intelligence models used for early prediction and evaluation of chronic kidney disease. Decis Anal J. 2023;6:100169.","journal-title":"Decis Anal J"},{"key":"1989_CR117","doi-asserted-by":"publisher","first-page":"17312","DOI":"10.1109\/ACCESS.2021.3053763","volume":"9","author":"P Chittora","year":"2021","unstructured":"Chittora P, Chaurasia S, Chakrabarti P, Kumawat G, Chakrabarti T, Leonowicz Z, et al. Prediction of chronic kidney disease-a machine learning perspective. IEEE Access. 2021;9:17312\u201334.","journal-title":"IEEE Access"},{"issue":"3","key":"1989_CR118","doi-asserted-by":"publisher","first-page":"568","DOI":"10.3390\/biomedicines12030568","volume":"12","author":"C Delrue","year":"2024","unstructured":"Delrue C, De Bruyne S, Speeckaert MM. Application of machine learning in chronic kidney disease: current status and future prospects. Biomedicines. 2024;12(3):568.","journal-title":"Biomedicines"},{"issue":"2","key":"1989_CR119","first-page":"20","volume":"5","author":"MH RAHMAN","year":"2025","unstructured":"RAHMAN MH, Rahaman M, Arafat Y, Rahat SRUI, Hasan R, RIMON STH, Dipa SA. Artificial intelligence for chronic kidney disease risk stratification in the USA: ensemble vs. deep learning methods. Br J Nurs Stud. 2025;5(2):20\u201332.","journal-title":"Br J Nurs Stud"},{"key":"1989_CR120","doi-asserted-by":"publisher","DOI":"10.1016\/j.iswa.2024.200397","volume":"22","author":"G Dharmarathne","year":"2024","unstructured":"Dharmarathne G, Bogahawaththa M, McAfee M, Rathnayake U, Meddage DPP. On the diagnosis of chronic kidney disease using a machine learning-based interface with explainable artificial intelligence. Intelligent Systems with Applications. 2024;22:200397.","journal-title":"Intelligent Systems with Applications"},{"issue":"10","key":"1989_CR121","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics15101225","volume":"15","author":"S Alobaidi","year":"2025","unstructured":"Alobaidi S. Emerging biomarkers and advanced diagnostics in chronic kidney disease: early detection through multi-omics and AI. Diagnostics. 2025;15(10):1225.","journal-title":"Diagnostics"},{"issue":"11\u201312","key":"1989_CR122","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.202400151","volume":"25","author":"M Rroji","year":"2025","unstructured":"Rroji M, Spasovski G. Omics studies in CKD: diagnostic opportunities and therapeutic potential. Proteomics. 2025;25(11\u201312):e202400151.","journal-title":"Proteomics"},{"issue":"1","key":"1989_CR123","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.70133","volume":"15","author":"X Shao","year":"2025","unstructured":"Shao X, Gao S, Bai P, Yang Q, Lin Y, Pang M, et al. Machine learning-based multi\u2010omics models for diagnostic classification and risk stratification in diabetic kidney disease. Clin Transl Med. 2025;15(1):e70133.","journal-title":"Clin Transl Med"},{"issue":"11\u201312","key":"1989_CR124","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.202500093","volume":"25","author":"G Glorieux","year":"2025","unstructured":"Glorieux G, Klein J, Latosinska A. Multi-disciplinary and omics\u2010driven approaches to advance personalized medicine in cardiovascular and chronic kidney disease. Proteomics. 2025;25(11\u201312):e00093.","journal-title":"Proteomics"},{"key":"1989_CR125","doi-asserted-by":"publisher","first-page":"923068","DOI":"10.3389\/fneph.2022.923068","volume":"2","author":"C Hill","year":"2022","unstructured":"Hill C, Avila-Palencia I, Maxwell AP, Hunter RF, McKnight AJ. Harnessing the full potential of multi-omic analyses to advance the study and treatment of chronic kidney disease. Front Nephrol. 2022;2:923068.","journal-title":"Front Nephrol"},{"issue":"5","key":"1989_CR126","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.186070","volume":"10","author":"F Alakwaa","year":"2025","unstructured":"Alakwaa F, Das V, Majumdar A, Nair V, Fermin D, Dey AB, et al. Leveraging complementary multi-omics data integration methods for mechanistic insights in kidney diseases. JCI Insight. 2025;10(5):e186070.","journal-title":"JCI Insight"},{"key":"1989_CR127","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.202400108","author":"MB Lopes","year":"2025","unstructured":"Lopes MB, Coletti R, Duranton F, Glorieux G, Jaimes Campos MA, Klein J, et al. The omics\u2010driven machine learning path to cost\u2010effective precision medicine in chronic kidney disease. Proteomics. 2025. https:\/\/doi.org\/10.1002\/pmic.202400108.","journal-title":"Proteomics"},{"issue":"1","key":"1989_CR128","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1053\/j.akdh.2022.11.005","volume":"30","author":"N Grobe","year":"2023","unstructured":"Grobe N, Scheiber J, Zhang H, Garbe C, Wang X. Omics and artificial intelligence in kidney diseases. Adv Kidney Disease Health. 2023;30(1):47\u201352.","journal-title":"Adv Kidney Disease Health"},{"key":"1989_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmccpl.2025.100290","volume":"11","author":"JM Bastos","year":"2025","unstructured":"Bastos JM, Cola\u00e7o B, Baptista R, Gavina C, Vitorino R. Innovations in heart failure management: the role of cutting-edge biomarkers and multi-omics integration. Journal of Molecular and Cellular Cardiology Plus. 2025;11:100290.","journal-title":"Journal of Molecular and Cellular Cardiology Plus"},{"issue":"2","key":"1989_CR130","doi-asserted-by":"publisher","DOI":"10.1111\/dme.15447","volume":"42","author":"C Hill","year":"2025","unstructured":"Hill C, McKnight AJ, Smyth LJ. Integrated multiomic analyses: an approach to improve understanding of diabetic kidney disease. Diabet Med. 2025;42(2):e15447.","journal-title":"Diabet Med"},{"key":"1989_CR131","doi-asserted-by":"publisher","first-page":"1572034","DOI":"10.3389\/fimmu.2025.1572034","volume":"16","author":"H Yan","year":"2025","unstructured":"Yan H, Ji X, Li B. Advancing personalized, predictive, and preventive medicine in bladder cancer: a multi-omics and machine learning approach for novel prognostic modeling, immune profiling, and therapeutic target discovery. Front Immunol. 2025;16:1572034.","journal-title":"Front Immunol"},{"key":"1989_CR132","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2025.123396","volume":"363","author":"S Chi","year":"2025","unstructured":"Chi S, Ma J, Ding Y, Lu Z, Zhou Z, Wang M, et al. Integrated multi-omics analysis identifies a machine learning-derived signature for predicting prognosis and therapeutic vulnerability in clear cell renal cell carcinoma. Life Sci. 2025;363:123396.","journal-title":"Life Sci"},{"issue":"7","key":"1989_CR133","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v16.i7.106218","volume":"16","author":"CM Song","year":"2025","unstructured":"Song CM, Lin TH, Huang HT, Yao JY. Illuminating diabetes via multi-omics: unraveling disease mechanisms and advancing personalized therapy. World J Diabetes. 2025;16(7):106218.","journal-title":"World J Diabetes"},{"issue":"2","key":"1989_CR134","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s13167-023-00327-3","volume":"14","author":"J Liu","year":"2023","unstructured":"Liu J, Shi Y, Zhang Y. Multi-omics identification of an immunogenic cell death-related signature for clear cell renal cell carcinoma in the context of 3P medicine and based on a 101-combination machine learning computational framework. EPMA J. 2023;14(2):275\u2013305.","journal-title":"EPMA J"},{"key":"1989_CR135","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202412775","author":"Z Dong","year":"2025","unstructured":"Dong Z, Li P, Jiang Y, Wang Z, Fu S, Che H, et al. Integrative Multi-Omics and Routine Blood Analysis Using Deep Learning: cost\u2010effective early prediction of chronic disease risks. Adv Sci. 2025. https:\/\/doi.org\/10.1002\/advs.202412775.","journal-title":"Adv Sci"},{"key":"1989_CR136","doi-asserted-by":"publisher","DOI":"10.22270\/jddt.v15i5.7112","author":"TA Ikwelle","year":"2025","unstructured":"Ikwelle TA, Ihim AC, Ozuruoke DF, Obi PC, Obi CU, Onuora IJ, et al. Multi-Omics Integration in Personalized Medicine: advancing laboratory diagnostics and precision therapeutics in the era of individualized healthcare. Journal of Drug Delivery & Therapeutics. 2025. https:\/\/doi.org\/10.22270\/jddt.v15i5.7112.","journal-title":"Journal of Drug Delivery & Therapeutics"},{"key":"1989_CR137","doi-asserted-by":"crossref","unstructured":"Tiwari P, Pandey R, Chadha S. (2025). Integrative Multi-Omics Approaches for Personalized Medicine and Health. Current Bioinformatics.","DOI":"10.2174\/0115748936360644250127095005"},{"issue":"1","key":"1989_CR138","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.30574\/ijsra.2023.8.1.0189","volume":"8","author":"H Ali","year":"2023","unstructured":"Ali H. Artificial intelligence in multi-omics data integration: advancing precision medicine, biomarker discovery and genomic-driven disease interventions. Int J Sci Res Arch. 2023;8(1):1012\u201330.","journal-title":"Int J Sci Res Arch"},{"issue":"1","key":"1989_CR139","doi-asserted-by":"publisher","DOI":"10.1007\/s11934-025-01276-2","volume":"26","author":"F Gavi","year":"2025","unstructured":"Gavi F, Sighinolfi MC, Pallotta G, Assumma S, Panio E, Fettucciari D, et al. Multiomics in Renal Cell Carcinoma: current landscape and future directions for precision medicine. Curr Urol Rep. 2025;26(1):44.","journal-title":"Curr Urol Rep"},{"key":"1989_CR140","unstructured":"Huang J. (2023). Multi-omics of chronic kidney disease in individuals with pre-diabetes or type 2 diabetes in the era of precision health (Doctoral dissertation, lmu)."},{"issue":"3","key":"1989_CR141","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41588-024-01662-5","volume":"56","author":"J Hu","year":"2024","unstructured":"Hu J, Wang SG, Hou Y, Chen Z, Liu L, Li R, et al. Multi-omic profiling of clear cell renal cell carcinoma identifies metabolic reprogramming associated with disease progression. Nat Genet. 2024;56(3):442\u201357.","journal-title":"Nat Genet"},{"issue":"1","key":"1989_CR142","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-022-00713-7","volume":"5","author":"IW Wu","year":"2022","unstructured":"Wu IW, Tsai TH, Lo CJ, Chou YJ, Yeh CH, Chan YH, et al. Discovering a trans-omics biomarker signature that predisposes high risk diabetic patients to diabetic kidney disease. NPJ Digit Med. 2022;5(1):166.","journal-title":"NPJ Digit Med"},{"key":"1989_CR143","unstructured":"Chi S, Ma J, Ding Y, Zhou Z, Wang M, Li G, Chen Y. Integrated Multi-Omics Analysis Identities a Consensus Machine Learning-Derived Signature for Predicting Prognosis and Therapeutic Vulnerability in Clear Cell Renal Cell Carcinoma. Available at SSRN 4826092."},{"issue":"3","key":"1989_CR144","doi-asserted-by":"publisher","first-page":"193","DOI":"10.55670\/fpll.futech.4.3.18","volume":"4","author":"W Li","year":"2025","unstructured":"Li W, Chandran SP. Machine learning-based integration of multi-omics data for identification of tubular epithelial cell-specific biomarkers in diabetic nephropathy. Future Technol. 2025;4(3):193\u2013203.","journal-title":"Future Technol"},{"key":"1989_CR145","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1250340","volume":"10","author":"C Zhan","year":"2023","unstructured":"Zhan C, Tang T, Wu E, Zhang Y, He M, Wu R, et al. From multi-omics approaches to personalized medicine in myocardial infarction. Front Cardiovasc Med. 2023;10:1250340.","journal-title":"Front Cardiovasc Med"},{"issue":"5","key":"1989_CR146","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1093\/bfgp\/elae013","volume":"23","author":"D Acharya","year":"2024","unstructured":"Acharya D, Mukhopadhyay A. A comprehensive review of machine learning techniques for multi-omics data integration: challenges and applications in precision oncology. Brief Funct Genomics. 2024;23(5):549\u201360.","journal-title":"Brief Funct Genomics"},{"issue":"1","key":"1989_CR147","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06425-2","volume":"23","author":"M Lin","year":"2025","unstructured":"Lin M, Guo J, Gu Z, Tang W, Tao H, You S, et al. Machine learning and multi-omics integration: advancing cardiovascular translational research and clinical practice. J Transl Med. 2025;23(1):388.","journal-title":"J Transl Med"},{"key":"1989_CR148","doi-asserted-by":"crossref","unstructured":"Kheto A, Mohapatra S. Data integration techniques in urinary omics. Exploring noninvasive disease biomarkers with urinary omics analysis. Academic; 2025. pp. 311\u201340.","DOI":"10.1016\/B978-0-443-33574-7.00015-8"},{"key":"1989_CR149","doi-asserted-by":"publisher","first-page":"1342837","DOI":"10.3389\/fimmu.2024.1342837","volume":"15","author":"X Hu","year":"2024","unstructured":"Hu X, Chen S, Ye S, Chen W, Zhou Y. New insights into the role of immunity and inflammation in diabetic kidney disease in the omics era. Front Immunol. 2024;15:1342837.","journal-title":"Front Immunol"},{"key":"1989_CR150","doi-asserted-by":"crossref","unstructured":"Wang, T., Li, L., Liu, L., Tan, R., Wu, Q., Zhu, X.,... Yin, Z. (2025). Overview of pharmacodynamical research of traditional Chinese medicine on hyperuricemic nephropathy: from the perspective of dual-regulatory effect on the intestines and kidneys. Frontiers in Pharmacology, 16, 1517047. doi: 10.3389\/fphar.2025.1517047","DOI":"10.3389\/fphar.2025.1517047"},{"issue":"7","key":"1989_CR151","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26073125","volume":"26","author":"Y Zhu","year":"2025","unstructured":"Zhu Y, Yu S, Yang D, Yu T, Liu Y, Du W. Integrated multi-omics analysis unveils distinct molecular subtypes and a robust immune\u2013metabolic prognostic model in clear cell renal cell carcinoma. Int J Mol Sci. 2025;26(7):3125.","journal-title":"Int J Mol Sci"},{"key":"1989_CR152","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1520436","volume":"16","author":"J Song","year":"2025","unstructured":"Song J, Wang C, Zhao T, Zhang Y, Xing J, Zhao X, et al. Multi-omics approaches for biomarker discovery and precision diagnosis of prediabetes. Front Endocrinol. 2025;16:1520436.","journal-title":"Front Endocrinol"},{"issue":"23","key":"1989_CR153","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.2217\/fon-2020-0119","volume":"16","author":"A John","year":"2020","unstructured":"John A, Qin B, Kalari KR, Wang L, Yu J. Patient-specific multi-omics models and the application in personalized combination therapy. Future Oncol. 2020;16(23):1737\u201350.","journal-title":"Future Oncol"},{"issue":"4","key":"1989_CR154","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1080\/14789450.2020.1772058","volume":"17","author":"F Raimondo","year":"2020","unstructured":"Raimondo F, Pitto M. Prognostic significance of proteomics and multi-omics studies in renal carcinoma. Expert Rev Proteomics. 2020;17(4):323\u201334.","journal-title":"Expert Rev Proteomics"},{"issue":"8","key":"1989_CR155","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26083635","volume":"26","author":"V Jacob","year":"2025","unstructured":"Jacob V, de Berny Q, Brazier F, Presne C, Lion J, Ouled-Haddou H, et al. Quantification of urine and plasma levels of extracellular vesicles in a cohort of kidney transplant recipients and chronic kidney disease patients. Int J Mol Sci. 2025;26(8):3635.","journal-title":"Int J Mol Sci"},{"issue":"18","key":"1989_CR156","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21186547","volume":"21","author":"LJ Peters","year":"2020","unstructured":"Peters LJ, Floege J, Biessen EA, Jankowski J, van der Vorst EP. MicroRNAs in chronic kidney disease: four candidates for clinical application. Int J Mol Sci. 2020;21(18):6547.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"1989_CR157","doi-asserted-by":"publisher","first-page":"6915","DOI":"10.1007\/s00210-024-03669-5","volume":"398","author":"SM Al-Tantawy","year":"2025","unstructured":"Al-Tantawy SM, Eraky SM, Eissa LA. Novel therapeutic target for diabetic kidney disease through downregulation of miRNA-192-5p and miRNA-21-5p by celastrol: implication of autophagy, oxidative stress, and fibrosis. Naunyn Schmiedebergs Arch Pharmacol. 2025;398(6):6915\u201328.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"1989_CR158","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.krcp.2011.12.001","volume":"31","author":"HY Lan","year":"2012","unstructured":"Lan HY. Smads as therapeutic targets for chronic kidney disease. Kidney Res Clin Pract. 2012;31(1):4\u201311.","journal-title":"Kidney Res Clin Pract"},{"issue":"2","key":"1989_CR159","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24021792","volume":"24","author":"DD Motshwari","year":"2023","unstructured":"Motshwari DD, Matshazi DM, Erasmus RT, Kengne AP, Matsha TE, George C. MicroRNAs associated with chronic kidney disease in the general population and high-risk subgroups\u2014a systematic review. Int J Mol Sci. 2023;24(2):1792.","journal-title":"Int J Mol Sci"},{"key":"1989_CR160","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1310023","volume":"14","author":"YF Zeng","year":"2023","unstructured":"Zeng YF, Li JY, Wei XY, Ma SQ, Wang QG, Qi Z, et al. Preclinical evidence of reno-protective effect of quercetin on acute kidney injury: a meta-analysis of animal studies. Front Pharmacol. 2023;14:1310023.","journal-title":"Front Pharmacol"},{"key":"1989_CR161","doi-asserted-by":"crossref","unstructured":"Secondulfo F, Del Vecchio Blanco F, Capolongo G, Piluso G, Nigro V, Perna AF, \u2026 Zacchia M. Genome-Based Advances in Modelling Renal Ciliopathies and Enhancing Patient Care. Kidney and Blood Pressure Research (2025).\u00a0","DOI":"10.1159\/000547131"},{"issue":"6","key":"1989_CR162","first-page":"558","volume":"10","author":"G Wang","year":"2024","unstructured":"Wang G, Liao M, Tan DJ, Chen X, Chao R, Zhu Y, et al. Advances in diagnosis and treatment of inherited kidney diseases in children. Kidney Dis. 2024;10(6):558\u201372.","journal-title":"Kidney Dis"},{"issue":"1","key":"1989_CR163","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-021-00977-7","volume":"19","author":"A Duan","year":"2021","unstructured":"Duan A, Wang H, Zhu Y, Wang Q, Zhang J, Hou Q, et al. Chromatin architecture reveals cell type-specific target genes for kidney disease risk variants. BMC Biol. 2021;19(1):38.","journal-title":"BMC Biol"},{"issue":"1","key":"1989_CR164","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38958-9","volume":"14","author":"H Kikuchi","year":"2023","unstructured":"Kikuchi H, Chou CL, Yang CR, Chen L, Jung HJ, Park E, et al. Signaling mechanisms in renal compensatory hypertrophy revealed by multi-omics. Nat Commun. 2023;14(1):3481.","journal-title":"Nat Commun"},{"issue":"6","key":"1989_CR165","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s12195-024-00825-y","volume":"17","author":"J Huang","year":"2024","unstructured":"Huang J, Wang X, Ge S, Lu X, Sun C. Organoids as sophisticated tools for renal cancer research: extensive applications and promising prospects. Cell Mol Bioeng. 2024;17(6):527\u201348.","journal-title":"Cell Mol Bioeng"},{"issue":"11","key":"1989_CR166","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.3390\/life15111680","volume":"15","author":"H Nakanoh","year":"2025","unstructured":"Nakanoh H, Tsuji K, Fukushima K, Uchida N, Haraguchi S, Kitamura S, Wada J. Kidney organoids: current advances and applications. Life. 2025;15(11):1680.","journal-title":"Life"},{"issue":"10","key":"1989_CR167","doi-asserted-by":"publisher","DOI":"10.3390\/jpm14101054","volume":"14","author":"N Van Roy","year":"2024","unstructured":"Van Roy N, Speeckaert MM. The potential use of targeted proteomics and metabolomics for the identification and monitoring of diabetic kidney disease. J Pers Med. 2024;14(10):1054.","journal-title":"J Pers Med"},{"issue":"1","key":"1989_CR168","doi-asserted-by":"publisher","first-page":"69","DOI":"10.4103\/ATMR.ATMR_24_25","volume":"2","author":"RA Alotaibi","year":"2025","unstructured":"Alotaibi RA, Alshahrani SS, Alotaibi HF, Alsaleh AK, Alharbi AK, Alharthi RT, et al. Predictive immunonutrition for paediatric chronic kidney disease surgery: a multi-omic data fusion framework through canonical correlation analysis. J Adv Trends Med Res. 2025;2(1):69\u201375.","journal-title":"J Adv Trends Med Res"},{"key":"1989_CR169","doi-asserted-by":"crossref","unstructured":"Kaur J, Kamboj K, Yadav AK. Clinical applications of urinary omics in renal disorders. Exploring noninvasive disease biomarkers with urinary omics analysis. Academic; 2025. pp. 247\u201381.","DOI":"10.1016\/B978-0-443-33574-7.00008-0"},{"issue":"9","key":"1989_CR170","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26094268","volume":"26","author":"Y Xu","year":"2025","unstructured":"Xu Y, Wu J, Chen C, Ouyang J, Li D, Shi T. EMitool: explainable multi-omics integration for disease subtyping. Int J Mol Sci. 2025;26(9):4268.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"1989_CR171","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1159\/000543640","volume":"149","author":"T McDonnell","year":"2025","unstructured":"McDonnell T, Banks RE, Taal MW, Vuilleumier N, Kalra PA. Personalized care in CKD: moving beyond traditional biomarkers. Nephron. 2025;149(6):339\u201357.","journal-title":"Nephron"},{"key":"1989_CR172","doi-asserted-by":"publisher","first-page":"102524","DOI":"10.1016\/j.tranon.2025.102524","volume":"61","author":"W Gong","year":"2025","unstructured":"Gong W, Ge M, Xi X, Lu Z, Zhang X, Chen D, et al. Alad as a prognostic biomarker regulates metabolism and immune responses in renal cell carcinoma through multi-omics analysis. Transl Oncol. 2025;61:102524.","journal-title":"Transl Oncol"},{"key":"1989_CR173","doi-asserted-by":"crossref","unstructured":"Savitha S, Keerthana R, Logeswaran K, Keerthika P, Sharmila V, Sangeetha M. Integration of Multi-Omics data: Genomics, Proteomics, metabolomics. Harnessing AI and machine learning for precision wellness. IGI Global Scientific Publishing; 2025. pp. 149\u201384.","DOI":"10.4018\/979-8-3693-9521-9.ch006"},{"issue":"5","key":"1989_CR174","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/path.5022","volume":"244","author":"JJ Hsieh","year":"2018","unstructured":"Hsieh JJ, Le V, Cao D, Cheng EH, Creighton CJ. Genomic classifications of renal cell carcinoma: a critical step towards the future application of personalized kidney cancer care with pan-omics precision. J Pathol. 2018;244(5):525\u201337.","journal-title":"J Pathol"},{"issue":"2","key":"1989_CR175","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00441-021-03470-3","volume":"385","author":"MT Lindenmeyer","year":"2021","unstructured":"Lindenmeyer MT, Alakwaa F, Rose M, Kretzler M. Perspectives in systems nephrology. Cell Tissue Res. 2021;385(2):475\u201388.","journal-title":"Cell Tissue Res"},{"issue":"5","key":"1989_CR176","doi-asserted-by":"publisher","first-page":"58","DOI":"10.70749\/ijbr.v3i5.1480","volume":"3","author":"A Iftikhar","year":"2025","unstructured":"Iftikhar A, Ishtiaq Q, Uzair M, Nazir QA, Ch AS, Khan ZA. Novel biomarkers in the early detection of chronic kidney disease: current evidence and future directions. Indus Journal of Bioscience Research. 2025;3(5):58\u201366.","journal-title":"Indus Journal of Bioscience Research"},{"issue":"4","key":"1989_CR177","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s13167-022-00304-2","volume":"13","author":"N Jain","year":"2022","unstructured":"Jain N, Nagaich U, Pandey M, Chellappan DK, Dua K. Predictive genomic tools in disease stratification and targeted prevention: a recent update in personalized therapy advancements. EPMA J. 2022;13(4):561\u201380.","journal-title":"EPMA J"}],"updated-by":[{"DOI":"10.1007\/s10238-026-02289-y","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000}}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01989-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-025-01989-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01989-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T16:02:25Z","timestamp":1787155345000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-025-01989-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,6]]},"references-count":177,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1989"],"URL":"https:\/\/doi.org\/10.1007\/s10238-025-01989-1","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,6]]},"assertion":[{"value":"17 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been retracted. Please see the Retraction Notice for more detail:","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s10238-026-02289-y","URL":"https:\/\/doi.org\/10.1007\/s10238-026-02289-y","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests that may have influenced in this manuscript.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that Gen AI and large language model (LLM) were used in the creation of this manuscript. Generative AI items like instatext, wordvice, and DeepL were used for structural editing and improve handwriting of the text.","order":2,"name":"Ethics","label":"Generative AI statement","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"94"}}